TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PolyPeptide Laboratories (Sweden) AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
102,676
|
96,095
|
80,994 |
| Financial expenses |
1,272
|
2,116
|
331 |
| Earnings before taxes |
28,139
|
17,474
|
26,925 |
| EBITDA |
31,896
|
23,322
|
25,035 |
| Total assets |
230,021
|
179,465
|
136,323 |
| Current assets |
148,288
|
119,431
|
80,454 |
| Current liabilities |
52,475
|
37,599
|
28,287 |
| Equity capital |
76,427
|
100,883
|
94,038 |
| - share capital |
1,001
|
1,036
|
1,033 |
| Employees (average) |
350
|
312
|
325 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.2%
|
56.2%
|
69.0% |
| Turnover per employee |
293
|
308
|
249 |
| Profit as a percentage of turnover |
27.4%
|
18.2%
|
33.2% |
| Return on assets (ROA) |
12.8%
|
10.9%
|
20.0% |
| Current ratio |
282.6%
|
317.6%
|
284.4% |
| Return on equity (ROE) |
36.8%
|
17.3%
|
28.6% |
| Change turnover |
9,848
|
14,865
|
-6,817 |
| Change turnover % |
11%
|
18%
|
-8% |
| Chg. No. of employees |
38
|
-13
|
28 |
| Chg. No. of employees % |
12%
|
-4%
|
9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.